History and exam

Key diagnostic factors

common

presence of risk factors

Key risk factors include working/living/travelling to endemic areas, and exposure to mosquitoes.

acute onset of fever

Patients with VEEV infection frequently have acute onset fever (92% to 99%), which lasts around 3 to 4 days.[5][27][32]

Most patients presenting with fever will also be tachycardic and/or tachypnoeic.

headache

Reported in 56% to 98% of patients with VEEV infection.​[4][5]​​[27]

May have a higher intensity, or its intensity may increase progressively, in those with VEEV infection who develop severe neurological disease.

myalgia

Reported in around 95% of patients with VEEV infection.[5]

arthralgia

Reported in around 88% of patients with VEEV infection.[5]

Other diagnostic factors

common

retro-orbital pain

Reported in around 84% of patients with VEEV infection.[5]

tachypnoea

May occur during early stages of VEEV infection.[3][33]

Often presents with fever.

tachycardia

May occur during early stages of VEEV infection.[3][33]

Often presents with fever.

chills

Reported in around 85% of patients with VEEV infection.​[4][5]

altered mental status

In a large outbreak in Venezuela in 1995, around 91% of 313 patients hospitalised with Venezuelan equine encephalitis (VEE) infection presented with altered mental status.[4][27]

Mostly seen in children.[4][27]

Neurological complications appear to be more prevalent among the epizootic VEEV subtypes (IAB and IC) compared with the enzootic subtypes.[4]

nausea/vomiting

Reported in around 55% to 60% of patients with VEEV infection.​[4][5]​​[27]

uncommon

seizures

Occurs in around 3% of patients with VEEV infection. Mostly seen in children.​[4][5]​​[27][32]

The onset of seizures ranges from day 1 to 10 after the onset of fever.​[4][5]​​[27][32]

In a large outbreak in Venezuela in 1995, 70.6% of 313 patients hospitalised with encephalitis resulting from VEEV infection presented with seizures.[27]

Neurological complications appear to be more prevalent among the epizootic VEEV subtypes (IAB and IC) compared with the enzootic subtypes.[4]

gastrointestinal bleeding

Reported in severe cases of VEEV infection.[4]

Haemorrhage and/or bleeding diathesis may result in the presence of palor, petechiae, haematemesis, melaena, haematuria, and epistaxis.[4]

rhinorrhoea

Reported in around 10% of patients with VEEV infection.​[4][5]

cough

Reported in around 27% of patients with VEEV infection.[5]

diarrhoea

Reported in around 23% of patients with VEEV infection.​[4][5]

rash

Reported in 1% to 9% of patients; however, also seen in around 25% of patients with dengue fever.[11]

sore throat

Reported in around 16% of patients with VEEV infection.[5]

hemiparesis

Reported in around 11% of hospitalised patients with VEEV infection.[9]

A sign of neurological involvement. The onset of neurological symptoms usually occurs several days into the course of illness.

Neurological symptoms appear to be more prevalent among children (up to 36% of symptomatic children).[9][11][14] Furthermore, neurological complications appear to be more prevalent among the epizootic VEEV subtypes (IAB and IC) compared with the enzootic subtypes.[4]

lethargy, drowsiness, or confusion

A sign of neurological involvement. The onset of neurological symptoms usually occurs several days into the course of illness.

Neurological symptoms appear to be more prevalent among children (up to 36% of symptomatic children).[9][11][14] Furthermore, neurological complications appear to be more prevalent among the epizootic VEEV subtypes (IAB and IC) compared with the enzootic subtypes.[4]

paraesthesias

A sign of neurological involvement. The onset of neurological symptoms usually occurs several days into the course of illness.

Neurological symptoms appear to be more prevalent among children (up to 36% of symptomatic children).[9][11][14] Furthermore, neurological complications appear to be more prevalent among the epizootic VEEV subtypes (IAB and IC) compared with the enzootic subtypes.[4]

ataxia/gait abnormalities

A sign of neurological involvement. The onset of neurological symptoms usually occurs several days into the course of illness.

Neurological symptoms appear to be more prevalent among children (up to 36% of symptomatic children).[9][11][14] Furthermore, neurological complications appear to be more prevalent among the epizootic VEEV subtypes (IAB and IC) compared with the enzootic subtypes.[4]

behavioural abnormalities

Reported in 11% of hospitalised patients with VEEV infection.[9]

A sign of neurological involvement. The onset of neurological symptoms usually occurs several days into the course of illness.

Neurological symptoms appear to be more prevalent among children (up to 36% of symptomatic children).[9][11][14] Furthermore, neurological complications appear to be more prevalent among the epizootic VEEV subtypes (IAB and IC) compared with the enzootic subtypes.[4]

stupor, somnolence, or coma

Reported in 3% of hospitalised patients with VEEV infection.[9]

Patients with central nervous system involvement can progress to somnolence and coma within days.[3][9] In such patients, mortality is high (up to 10%).[9]

neck stiffness (nuchal rigidity)

Reported in 10% to 19% of patients with VEEV infection.[11]

A sign of neurological involvement, particularly when an intense headache is also present. The onset of neurological symptoms usually occurs several days into the course of illness.

Neurological symptoms appear to be more prevalent among children (up to 36% of symptomatic children).[9][11][14] Furthermore, neurological complications appear to be more prevalent among the epizootic VEEV subtypes (IAB and IC) compared with the enzootic subtypes.[4]

jaundice

A sign of liver failure. Mentioned in case reports of patients with VEEV infection.[4]

papilloedema

Fundoscopic examination may reveal papilloedema.

Papilloedema indicates neurological involvement. The onset of neurological symptoms usually occurs several days into the course of illness.

Neurological symptoms appear to be more prevalent among children (up to 36% of symptomatic children).[9][11][14] Furthermore, neurological complications appear to be more prevalent among the epizootic VEEV subtypes (IAB and IC) compared with the enzootic subtypes.[4]

Risk factors

strong

living and/or working in or near tropical forests in Central or South America

Particularly in or around areas where an epizootic outbreak is occurring (i.e., involving horses).

In a cross-sectional study carried out in Darién (Panama), working in forests in endemic regions was associated with a higher risk of being seropositive for Venezuelan equine encephalitis (adjusted odds ratio [OR] 3.8, p = 0.01).[26] This was likely mediated by increased exposure to the mosquito vectors (Culex [Melanoconion] species).

In a study carried out in Iquitos (Peru), occupations involving outdoor work (e.g., labourer or lumberjack) in forest areas were found to confer significant risk for VEEV seropositivity (adjusted OR 3.4).[12]

fishing in or near tropical forests in Central or South America

Particularly in or around areas where an epizootic outbreak is occurring (i.e., involving horses).

In a cross-sectional study carried out in Darién (Panama), fishing was associated with a higher risk of being seropositive for Venezuelan equine encephalitis (adjusted OR 10.8, p = 0.001).[26] This was likely mediated by increased exposure to the mosquito vectors (Culex [Melanoconion] species).

age <15 years

Children with VEEV infection are at higher risk for developing neurological complications (e.g., encephalitis) compared with adults.

In a large outbreak in Venezuela in 1995, 92.3% of 313 patients hospitalised with Venezuelan equine encephalitis (VEE) presented with fever, 90.7% with altered mental status, 70.6% with seizures, 55.9% with headache, and 54.6% with vomiting.[27] Among those hospitalised with VEE, 75.7% were under the age of 15 years. Furthermore, an outbreak of epizootic VEEV in Texas (US) found that 10/28 (36%) symptomatic children had central nervous system involvement, compared to 6/51 (12%) adults.[11]

occupational exposure (laboratory)

Aerosolised transmission of VEEV has been documented in the laboratory setting.

Handling high virus concentrations, mouth pipetting, and engaging in activities that generate aerosols (e.g., tissue homogenisation, centrifugation) are risk factors for occupational infection.[1]

weak

bioterrorism

VEEV is considered a potential bioterrorism weapon as it can be produced in large amounts in aerosolised form.

In the US, VEEV (and other alphaviruses) is classified as a Category B agent by the Centers for Disease Control and Prevention (CDC), which is the second highest threat category.

Use of this content is subject to our disclaimer